Answer from: Medical Oncologist at Academic Institution
The standard starting dose for ponatinib is 45 mg. That being said, many clinicians lower the dose to 30 mg or 15 mg once a response is achieved in an effort to lower the rates of adverse events. The ongoing OPTIC study is evaluating if it is safe/effective to start at lower doses. An interim analys...
Comments
Medical Oncologist at Los Angeles VA Medical Center Updated with OPTIC primary analysis from ASCO 2021...
Updated with OPTIC primary analysis from ASCO 2021...